These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6344983)

  • 1. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas.
    Omura GA; Major FJ; Blessing JA; Sedlacek TV; Thigpen JT; Creasman WT; Zaino RJ
    Cancer; 1983 Aug; 52(4):626-32. PubMed ID: 6344983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovary.
    Baker TR; Piver MS; Caglar H; Piedmonte M
    Am J Clin Oncol; 1991 Jun; 14(3):246-50. PubMed ID: 2031513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
    Borden EC; Amato DA; Rosenbaum C; Enterline HT; Shiraki MJ; Creech RH; Lerner HJ; Carbone PP
    J Clin Oncol; 1987 Jun; 5(6):840-50. PubMed ID: 3585441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract.
    Piver MS; DeEulis TG; Lele SB; Barlow JJ
    Gynecol Oncol; 1982 Dec; 14(3):319-23. PubMed ID: 6897542
    [No Abstract]   [Full Text] [Related]  

  • 5. Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.
    Pautier P; Genestie C; Fizazi K; Morice P; Mottet C; Haie-Meder C; Le Cesne A; Lhommé C
    Int J Gynecol Cancer; 2002; 12(6):749-54. PubMed ID: 12445254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide.
    Azizi F; Bitran J; Javehari G; Herbst AL
    Am J Obstet Gynecol; 1979 Feb; 133(4):379-81. PubMed ID: 433999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
    Baker LH; Frank J; Fine G; Balcerzak SP; Stephens RL; Stuckey WJ; Rivkin S; Saiki J; Ward JH
    J Clin Oncol; 1987 Jun; 5(6):851-61. PubMed ID: 3295129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD).
    Blum RH; Corson JM; Wilson RE; Greenberger JS; Canellos GP; Frei E
    Cancer; 1980 Oct; 46(8):1722-6. PubMed ID: 7427876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy of advanced sarcomas in adults with "CYOMAD" (S7).
    Lynch G; Magill GB; Sordillo P; Golbey RB
    Cancer; 1982 Nov; 50(9):1724-7. PubMed ID: 6981452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of metastatic soft tissue sarcoma with a combination of adriamycin and DTIC or adriamycin and ifosfamide.
    Weh HJ; Zügel M; Wingberg D; Schwarz R; Zornig C; Dietel M; Hossfeld DK
    Onkologie; 1990 Dec; 13(6):448-52. PubMed ID: 2128712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Pinedo HM; Bramwell VH; Mouridsen HT; Somers R; Vendrik CP; Santoro A; Buesa J; Wagener T; van Oosterom AT; van Unnik JA
    Cancer; 1984 May; 53(9):1825-32. PubMed ID: 6367947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin and adriamycin combination chemotherapy for uterine stromal sarcomas and mixed mesodermal tumors.
    Peters WA; Rivkin SE; Smith MR; Tesh DE
    Gynecol Oncol; 1989 Sep; 34(3):323-7. PubMed ID: 2767523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas.
    Piver MS; Lele SB; Marchetti DL; Emrich LJ
    J Surg Oncol; 1988 Aug; 38(4):233-9. PubMed ID: 3045423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
    Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.
    Omura GA; Blessing JA; Major F; Lifshitz S; Ehrlich CE; Mangan C; Beecham J; Park R; Silverberg S
    J Clin Oncol; 1985 Sep; 3(9):1240-5. PubMed ID: 3897471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemotherapy of uterine sarcomas].
    Bai P; Zhang W; Sun J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):80-2. PubMed ID: 11776610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose doxorubicin infusion therapy for disseminated mixed mesodermal sarcoma of the uterus.
    Gershenson DM; Kavanagh JJ; Copeland LJ; Edwards CL; Freedman RS; Wharton JT
    Cancer; 1987 Apr; 59(7):1264-7. PubMed ID: 3815302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tract.
    Jansen RL; van der Burg ME; Verweij J; Stoter G
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1131-3. PubMed ID: 3115787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
    Antman K; Crowley J; Balcerzak SP; Rivkin SE; Weiss GR; Elias A; Natale RB; Cooper RM; Barlogie B; Trump DL
    J Clin Oncol; 1993 Jul; 11(7):1276-85. PubMed ID: 8315425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adriamycin in localized and metastatic uterine sarcomas.
    Piver MS; Barlow JJ; Lele SB; Yazigi R
    J Surg Oncol; 1979; 12(3):263-5. PubMed ID: 388083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.